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1. Introduction 
Neurophysins (NPs) are proteins elaborated by cells 
of the hypothalamo-neurohypophysial system, and 
within this system there is a close association between 
the biosynthesis of each neurophysin and the biosyn- 
thesis of each neurohypophysial hormone [ 1,2]. This 
lead to the proposal of a classification based on this 
association [3-S]. In the rat, there are 3 major forms of 
these proteins which were formerly named rat neuro- 
physins I, II and III, according to their electrophoretic 
mobility at pH 9.5 [6,7]. Rat neurophysin I has been 
renamed vasopressin-associated neurophysin (VP-RNP), 
and rat neurophysin II renamed oxytocin-associated 
neurophysin (OT-RNP) [ 1,3]. Rat neurophysin III 
was found [8,9] to be a metabolic derivative of 
OT-RNP, and is now referred to as OT-RNP’ [2]. The 
close relationship between one neurophysin and one 
hormone is perhaps best exemplified by Brattleboro 
homozygotes, rats with hereditary diabetes insipidus 
[lo]. These rats have an apparent inability to syn- 
thesize vasopressin and VP-RNP (RNP I), while their 
synthesis of oxytocin, OT-RNP and OT-RNP’ is unim- 
paired [ 1,2,6]. The view now generally accepted is 
that each neurophysin and its hormone initially arise 
as parts of a common precursor molecule [ 1,2,11]. 
Amino acid sequences have been described for neuro- 
physins of the ox [i2,13], the pig [14,15], and the 
sheep [ 161 (mammals of the order Artiodactyla); for 
one neurophysin of the horse [ 171 (order Perissodac- 
tyla); and for one neurophysin of the whale [ 181 
(order Cetacea). Also, the amino acid sequence of the 
N-terminal 54-residues of oxytocin-associated human 
neurophysin has also been determined [4,19] (order 
Primates). The N-terminal 30-residues of rat neuro- 
physin I and rat neurophysin II (order Rodentia) have 
been identified in [ 201. 
ElsevierjNorth-Holland Biomedical Press 
This report concerns the determination of the 
N-terminal sequence of VP-RNP through 44 residues 
of OT-RNP through 40 residues, and of OT-RNP’ 
through 69 residues. Results are discussed in relation- 
ship to evolution of this group of proteins. 
2. Materials and methods 
Rat neurophysins were purified by described 
methods and their amino acid compositions reported 
[7]. Vasopressin-associated rat neurophysin was char- 
acterized by its identity with the protein absent from 
the neural lobes of Brattleboro homozygotes by elec- 
trophoresis at pH 9.5, and by use of specific radio- 
immunoassays. Oxytocin-associated neurophysins 
were also characterized by electrophoresis and radio- 
immunoassay [2,8]. 
Samples of VP-RNP, OT-RNP and OT-RNP’ 
(200 nmol, 2mg each) were reduced with 2-mercapto- 
ethanol (0.7 mmol) for 4 h and S-alkylated with 14C- 
labelled iodoacetamide (1.44 mmol; 0.17 mCi/mmol) 
in the presence of 8 M urea in 0.6 M Tris-HCl buffer 
at pH 8.6. The S-alkylated proteins were separated 
from other reaction products in the absence of light 
on 1 .O X 30 cm columns of Sephadex G-25 equili- 
brated with 0.2 M acetic acid, and the acid was 
removed by lyophilization. The extent of S-alkylation 
was examined by amino acid analysis on a Beckman 
121 MB amino acid analyser. 
Automated amino acid sequence analysis of each 
S-alkylated neurophysin was performed on a Beckman 
model 890C Sequencer utilizing a Quadrol buffer sys- 
tem [21]. All PTH-amino acids were analyzed byhigh- 
pressure chromatography (HPLC) and 14C was counted 
in a Packard scintillation spectrometer, model 3255. 
HPLC analysis of PTH-amino acids involved the use 
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of 6 gradient systems at ambient temperature on 
columns of octadecasilyl-silica resins: 
System 1: A system modified from that in [22] 
which employed a PBondapak Cl 8 column 
(3.9 mm X 30 cm) from Waters Assoc. It comprised 
two solvents and a linear gradient over 23 min from 
5545% solvent B and 10 min at final conditions. Sol- 
vent A was 100 ml methanol, 900 ml water, 2.5 ml 
acetic acid, 50 ~1 acetone, adjusted to pH 4.1 with 
10 M NaOH; solvent B was 900 ml methanol, 100 ml 
water, 0.25 ml acetic acid. Flow rate was 1.7 ml/min. 
This system resolved all PTH-amino acids except 
glycine-threonine, valine-methionine and phenyl- 
alanine-isoleucine. Absorbance was monitored at 
254 nm and 269 nm. Using this system and absorbance 
at 323 nm, oxidation products of PTH-threonine and 
PTH-serine are clearly identified. 
System 2: This system was performed on 
yBondapack Cl 8 columns. Conditions were identical 
to those described for system 1, except that solvent 
B comprised 900 ml methanol, 100 ml water and 
2.5 ml acetic acid, the flow rate was 2.0 ml/min, and 
the gradient was over 20 min. This system resolved all 
PTH-amino acids except alanine-glutamic acid, iso- 
leucine-phenylalanine and methonine-valine. 
System 3: This system was performed on 
PBondapack Cl 8 columns. It consisted of a two sol- 
vent linear gradient from 20-55% solvent B over 
30 min. Solvent A was water and solvent B was 90% 
acetonitrile-10% water (v/v). The flow rate was 
2.0 ml/mm and runs were performed at ambient 
temperature. Absorbance was monitored at 254 nm 
and 269 nm. This system clearly resolved PTH val- 
ine (27.63 + 0.11 min) from PTH-methionine 
(29.46 + 0.10 mm); and PTH-isoleucine (30.19 f 
0.08 min) from PTH-phenylalanine (30.56 + 0.10 min). 
System 4: A system was developed for Altex Ultra- 
sphere (5 pm particle size) ODS columns (4.6 mm X 
25 cm) which was based on gradient 2, above. This 
comprised two solvent linear gradient from 20-70% 
solvent B over 23 min. Solvent A was identical to that 
in system 1. Solvent B consisted of 450 ml methanol, 
375 ml acetonitrile, 175 ml water, and 0.25 ml acetic 
acid. Flow rate, 1.7 ml/mm. This system resolved all 
PTII-amino acids except glycine-glutamine and 
valine-methionine. Absorbance was monitored at 
254 nm and 269 nm. 
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System 5: This system, performed on Ultrasphere 
ODS columns comprised solvents A and B of system 
4 and had 3 linear gradients from 15-25% solvent B 
over 15 min, from 25-32% solvent B over 7 min, 
then from 32-70% B over 3 min. The flow rate was 
1.7 ml/min and absorbance was measured at 254 nm 
and 269 nm. This system clearly resolved glycine 
(15.78 f 0.10 mm), glutamine (17.15 * 0.12 min), 
and glutamic acid (21.45 _+ 0.12 min). 
System 6: This system, of solvents A and B from 
system 4, was performed on Ultrasphere ODS columns. 
It consisted of 3 linear gradients from 35-37% solvent 
B over 10 min, 37-45% solvent B over 10 min and 
45-80% B over 10 min. The flow rate was 2.0 ml/mm 
and absorbance was measured at 254 nm and 269 nm. 
This system resolved valine (26.62 rt 0.09 min) and 
methionine (26.91 f 0.08 min). 
All residues were identified by using at least two 
of the above systems. When doubt remained about 
the identity of a PTH product, that product was co- 
chromatographed with each of the pertinent PTH- 
amino acid standards. PTH amino acids used for refer. 
ence were obtained from the Sigma Chemical Co. 
HPLC was performed on a Beckman Unit, model 332 
plus model 1 OOA pump, an Hitachi model 155-40 vari- 
able wavelength spectrophotometer with flow cell, a 
model BD 41 dual pen recorder, and a model C-RIA 
Shimadzu Integrator recorder. Automation in sample 
handling for HPLC was possible through use of a WISP 
710A automatic sample injector from Waters Assoc. 
3. Results 
The combination of gradients on HPLC and counts 
for 14C utilized in this study unambiguously identified 
all PTH-amino acids, and afforded high sensitivity so 
that as little as 30 pmol PTH-amino acid could be 
clearly recognized at 254 nm. This sensitivity is 
increased by two when absorbance at 269 nm is used 
for detection. 
The identification of the N-terminal residues from 
l-44, with only ambiguity for residues 41 and 42 
was achieved from a single run on the sequencer of 
1 mg (100 nmol) VP-RNP. Similarly, an unambiguous 
identification of the N-terminal residues l-40 was 
made for 1 mg (100 nmol) OT-RNP. Using 2 mg 
(200 nmol) OT-RNP, we achieved identifications 
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through l-69 residues, with failure to clearly identify 
residues at positions 52, 53, 58, 59, 66 and 67 from 
the N-terminus. The partial sequences obtained for 
these proteins of the rat [order Rodentia] are com- 
pared in table 1 with the partial sequences of: bovine 
neurophysins I and II (residues l-69) representing 
order Artiodactyla [12,13], and proposed respective 
oxytocin-associated neurophysin (OT-VNP) and vaso- 
pressin-associated neurophysin (VP-BNP) of the ox; 
and human neurophysin I (residues l-54) represent- 
ing the order Primata, and the oxytocin-associated 
neurophysin (OT-BNP) of man [4 ,191. 
4. Discussion 
The amino acid sequence of VP-RNP (RNP I) 
obtained here is identical to that given through 33 
residues (including their uncertain assignment of Thrz, 
Sera) for rat NP-II 1201. Likewise, there is sequence 
identity through 33 steps with our OT-RNP (RNP II) 
and OT-RNP’ (RNP III), and the sequence found in 
[20] for rat NP-I. Rat neurophysin-I, the predominant 
neurophysin found in rat neural lobe, is VP-RNP 
[ 1,2,6], and the mistaken assignment of sequence data 
in [20] has led to erroneous comparisons with the 
oxytocin-associated and vasopressin-associated neuro- 
physins of other species [ 18,231. 
Neurophysins characteristically have variable and 
constant regions in their sequence. The N-terminal 9 
residues is a variable region, while the region from 
1 O-70 is highly conserved. This would appear to hold 
true for the rat neurophysins, because VP-RNP and 
OT-RNP have 6 differences in their sequences through 
the N-terminal nine residues, and only 3 differences 
in the next 30 residues. The N-terminal sequence 
identity of OT-RNP and OT-RNP’ through the 
sequenced 43 residues confirms the established meta- 
bolic relationship of these proteins [2,8,9]. The NPs 
of the order Rodentia show many similarities to NPs 
5 10 15 20 
Rat m-RNP' (RNPIII) 
OT-RNP (RNP II) 
Ala-Ala-Leu-Asp-Leu-Asp-Met-Arg-Lys-Cys-Leu-Pro-Cys-Gly-Pro-Gly-Gly-Lys-Gly-Arg- 
Ala-Ala-Leu-Asp-Leu-Asp-Met-Arg-Lys-Cys-Leu-Pro-Cys-Gly-Pro-Gly-Gly-Lys-Gly-Arg- 
VP-RNP (RNP I) Ala-Thr-Ser-Asp-~let-Glu-Leu-Arg-Gln-Cys-Leu-Pro-Cys-Gly-Pro-Gly-Gly-Lys-Gly-Arg- -- --- - 
ox OT-BNP (BNP I) -Val Val- Thr 
VP-BNP (BNP II) --Met-Ser-----Glu-TZ%---X~ -- -- - 
Man OT-HNP (HNP I) -----Pm-----Glu-Val -- 
25 30 35 40 
Rat m-RNP' (RNPIII) Cys-Phe-Gly-Pro-Ser-Ile-Cys-Cys-Ala-Asp-Glu-Leu-Gly-Cys-Phe-Val-Gly-~r-Ala-Glu- 
Ur-RNP (RNP II) Cys-Phe-Gly-Pro-Ser-Ile-Cys-Cys-Ala-Asp-Glu-Leu-Gly-Cys-Phe-Val-Gly-Thr-Ala-Glu- 
VP-RNP (RNP I) Cys-Phe-Gly-Pro-Ser-Ile-Cys-Cys-Ala-Asp-Glu-Leu-Gly-Cys-Phe-Leu-Gly-~r-Leu-Val- -- 
ox OT-BNP (BNP I) -1 - 
VP-BNP (BNP II) d- 
Man m-HNP (HNP I) Am----------6x- - 
45 50 55 60 
Rat m-RNP' (RNPIII) Ala-LewArg-Cys-Gln-Glu-Glu-Ser-Tyr-Leu-Pro-( )-( )-Cys-Gly-Ser-Gly-( )-( )-Pro- 
VP-RJ@ (RNP II) ( )-( )-Arg-Cys- 
Ox OT-BNP (BNP I) Asn- cln-------dys-- 
VP-BNP (BNP II) 
- 
.n, n- -cTii----------Are-- - 
Man m-HNP (HNP I) --Asn- 
65 
Rat m-RNP' (RNPIII) Cys-Gly-Ser-Gly-Gly-( )-( )-Ala-Ala- 
Ox UT-BNP (BNP I) 
VP-BNP (BNP II) 
Fig.1. Comparison of rat, ox, and human oxytocin-associated and vasopressin-associated neurophysins. The partial sequence data 
for 3 rat proteins is shown, while sequence identity with OT-RNP’ is shown by solid lines for the ox and human proteins. Sequence 
differences with OT-RNP’ are shown and underlined. Unidentified residues in rat proteins are indicated by parentheses. 
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of the orders Artiodactyla, Perissidactyla, Cetacea 
and Primata. Of even more significance are the simi- 
larities between OT-NPs and between VP-NPs which, 
for the NPs of rat, ox and man, are greater than with- 
in-species similarities. Considering the N-terminal vari- 
able region, VP-RNP and OT-RNP show 6 differences 
while there are only two differences (positions 2,s) 
between rat and ox VP-NPs. The OT-NPs of rat and 
man have 3 differences in this region (positions 3,6,7), 
and the OT-NPs of rat and ox also have 3 differences 
(‘positions 2,7,9): The ox and human proteins have 4 
differences among their N-terminal 9 residues. This 
similarity between VP-NPs and between OT-NPs sug- 
gests that neurophysins arose by gene duplication 
prior to speciation in the eutherian mammals. The 
data, however, do not support the MSEL- and VLDV- 
neurophysin concept advanced in [24]. Methionine is 
placed in position 5 of VP-RNP, and this would reduce 
their scheme for naming, at best, to SEL-neurophysins. 
Moreover, the OT-NP structures of fig.1 reduce the 
VLDV-scheme completely, as none of the residues 2, 
3,6 and 7 are the same for all 3 OT-NPs. For the con- 
served region 1 O-70, the rat neurophysins show varia- 
tion at those ‘permissible’ positions such as position 
36, shown for whale neurophysin [ 181; and position 
48, shown for sheep neurophysin [ 161. They also intro- 
duce residues 39,40 and 55 as other possible sites of 
variation among the NPs of eutherians. 
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